Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-26 @ 10:19 PM
Study NCT ID:
NCT04971512
Status:
TERMINATED
Last Update Posted:
2022-02-14
First Post:
2021-07-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.
Sponsor:
Enanta Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-02
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-12
First Submit QC Date:
None
Study First Post Date:
2021-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-02
Last Update Post Date:
2022-02-14
Last Update Post Date Type:
ACTUAL